| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 09/12/2007 | CN101032466A Furosemide orally taking solution and the application in supersonic inspection |
| 09/12/2007 | CN100336559C New-type liver spleen lymph gland magnetic resonance contrast medium and its preparing method |
| 09/11/2007 | CA2351636C A process for the recovery of iodine from aqueous solutions containing iodinated organic compounds |
| 09/11/2007 | CA2319571C Methods and compositions for detection and diagnosis of infectious diseases |
| 09/11/2007 | CA2181340C Method of storage of ultrasonic gas suspensions |
| 09/07/2007 | WO2007099924A1 Tumor-selective fluorescent dye |
| 09/07/2007 | WO2007084532A3 Combination therapy with parp inhibitors |
| 09/07/2007 | CA2643802A1 Methods for regulating neurotransmitter systems by inducing counteradaptations |
| 09/07/2007 | CA2643145A1 Bifunctional resorcinol, thioresorcinol, and dithioresorcinol derivative metal chelating conjugates |
| 09/07/2007 | CA2641513A1 Methods of treating inflammatory and autoimmune diseases with natalizumab |
| 09/07/2007 | CA2641160A1 Methods of treating inflammatory and autoimmune diseases with alpha-4 inhibitory compounds |
| 09/06/2007 | US20070207953 Host Defense Factor X (HDFX) |
| 09/06/2007 | US20070207087 Cycloalkyl triamine pentacarboxylate as ligands for paramagnetic metal complexes |
| 09/06/2007 | DE102007005838A1 Contrast agent, useful for an imaging procedure, comprises particles with a first component as contrast components and a second component as magnetic components, which has magnetic moment in external magnetic field |
| 09/05/2007 | EP1829565A1 A new bone mineral substitute |
| 09/05/2007 | EP1829557A2 Preparation of diagnostic agents |
| 09/05/2007 | EP1829556A1 NK-3 Receptor in vivo assay |
| 09/05/2007 | EP1829550A2 Methods for treating an ischemic disorder and improving stroke outcome |
| 09/05/2007 | EP1828129A1 Hydroxypyridinone derivatives, their metal complexes and their use in the production of conjugates with biomolecules |
| 09/05/2007 | EP1827508A2 Targeting agents for molecular imaging |
| 09/05/2007 | EP1827507A2 Biological systems analysis |
| 09/05/2007 | EP1827506A2 Targeting contrast agents or targeting therapeutic agents for molecular imaging and therapy |
| 09/05/2007 | EP1827505A2 Radioimaging |
| 09/05/2007 | CN101031811A 肿瘤成像方法 Tumor imaging methods |
| 09/05/2007 | CN101031324A Diagnostic agent for tumor |
| 09/05/2007 | CN101031287A Nanocell drug delivery system |
| 09/05/2007 | CN101028524A Supersonic microvesicle target positioning controlled-release/gene device and target transferring method |
| 09/05/2007 | CN100335139C Method and apparatus for producing contrast agents for magnetic resonance imaging |
| 09/05/2007 | CN100335138C Alzheimer's disease model mouse latent infected by human cytomegalovirus, and its establishing mehtod |
| 09/04/2007 | US7265100 Separation of regioisomers of metal phthalocyanines |
| 09/04/2007 | US7264794 Methods of in vivo cytometry |
| 09/04/2007 | US7264793 Numb protein expression inhibitors by Musashi |
| 09/04/2007 | US7264790 Contrast medium containing liposomes; diagnosis of vascular system disorders,cell proliferation; antitumor agents; antiinflammatory agents |
| 08/30/2007 | WO2007098020A2 Methods of screening patients for omega-3 fatty acid therapy |
| 08/30/2007 | WO2007097593A1 Magnetic nano-composite for contrast agent, intelligent contrast agent, drug delivery agent for simultaneous diagnosis and treatment, and separation agent for target substance |
| 08/30/2007 | WO2007097473A1 Organic magnetic nanocomplex having functional molecule introduced therein |
| 08/30/2007 | WO2007097318A1 Diagnostic marker |
| 08/30/2007 | WO2007047141A3 Transgenic ro s a26-luc i f eras e mice for bioluminescent imaging |
| 08/30/2007 | WO2007030571A3 Identification of targets and development of reagents for testing and molecular imaging of human disease |
| 08/30/2007 | WO2007025282A3 Use of fructose-based compounds for the diagnosis of cancer |
| 08/30/2007 | WO2006124740A3 Method of measuring the biological activity of an urotensin ii receptor |
| 08/30/2007 | WO2006028835A3 Use of thyroid hormone conversion inhibitors |
| 08/30/2007 | US20070203362 Preparation of iodixanol |
| 08/30/2007 | US20070203212 Method of treating osteoarthritis |
| 08/30/2007 | US20070203027 5-Aminolevulinic Acid Salt, Process For Producing The Same And Use Thereof |
| 08/30/2007 | US20070202120 Yellow Fever Mosquito Deoxyribonucleoside Kinases And Its Use |
| 08/30/2007 | US20070202048 Comprises gadodiamide, bone graft matrix, and osteoinductive factor comprising BMP-2 at concentration of 0.1-1.5 mg/ml, wherein concentration of gadodiamide is greater than concentration of BMP-2 in bone graft composition and bone graft composition induces bone formation; iodine-free |
| 08/30/2007 | US20070202047 Polyamine-substituted ligands for use as contrast agents |
| 08/30/2007 | US20070202046 Implantable device formed from polymer blends |
| 08/30/2007 | US20070202045 Serum albumin binding peptides for tumor targeting |
| 08/30/2007 | US20070202040 Supplying radionuclide to blood clot; ultrasonic imaging; diagnosis, therapy |
| 08/30/2007 | US20070200271 Implantable device prepared from melt processing |
| 08/30/2007 | US20070200268 Implantable device prepared from solution processing |
| 08/30/2007 | CA2642779A1 Superparamagnetic nanoparticles based on iron oxides with modified surface, method of their preparation and application |
| 08/30/2007 | CA2642264A1 Reca inhibitors with antibiotic activity, compositions and methods of use |
| 08/29/2007 | EP1826560A2 Methods for introducing heterologous cells into fish |
| 08/29/2007 | EP1824524A1 Magnetic resonance contrast media |
| 08/29/2007 | EP1824523A2 Method of cardiac imaging with the use of hyperpolarized 13c-pyruvate |
| 08/29/2007 | EP1824522A2 Fluorescent contrast agents |
| 08/29/2007 | EP1824521A2 Ultrasound contrast agents for molecular imaging |
| 08/29/2007 | EP1604673B1 Auxiliary agent to be used in cancer therapy by dielectric heating and cancer therapy method |
| 08/29/2007 | EP1511376A4 Transgenic zebrafish models for thrombosis |
| 08/29/2007 | CN101027310A Radicals and their use as paramagnetic agents in a dynamic nuclear polarisation process |
| 08/29/2007 | CN101027099A Diagnostic marker for cancer |
| 08/29/2007 | CN101024729A Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use |
| 08/29/2007 | CN101023945A Use of non-periphery substituted phthalocyaniu metal complex |
| 08/29/2007 | CN100333798C Naloxone eye drops |
| 08/28/2007 | US7262279 A lactoferrin having an N-terminal lactoferrin variant in combination with an effective amount of an antidiabetic drug useful for decreaing blood levels of glucose and insulin thereby treating diabetes mellitus. monitoring the level of glycosylated hemoglobin (HbA1c); delayed release; hyperglycemia |
| 08/28/2007 | US7262050 Humanised antibodies |
| 08/28/2007 | US7261876 Multimeric proteins for use in the treatment and detection of cell proliferative disorders |
| 08/23/2007 | WO2007095443A2 Gastrin releasing peptide compounds |
| 08/23/2007 | WO2007094683A1 Contrast agents |
| 08/23/2007 | WO2007094680A1 Contrast agents |
| 08/23/2007 | WO2007094677A1 Contrast agents |
| 08/23/2007 | WO2007093451A2 Multimodal imaging using a three compartment polymer nanoparticle with cell specificity |
| 08/23/2007 | WO2005123907A3 Ex-vivo application of solid microparticulate therapeutic agents |
| 08/23/2007 | WO2005107818A3 Nanoparticles and their use for multifunctional bioimaging |
| 08/23/2007 | WO2005035003A9 Compositions and methods for increasing drug efficiency |
| 08/23/2007 | US20070198232 Estimation of clinical cut-offs |
| 08/23/2007 | US20070197954 Medical devices with enhanced ultrasonic visibilty |
| 08/23/2007 | US20070197953 Magnetic particles for therapeutic treatment |
| 08/23/2007 | US20070196369 MHC-peptide complex binding ligands |
| 08/23/2007 | US20070196284 Micelles associated to outer surface of liposome envelope by electrostatic interaction; active compound incorporated into the micelles linking a large amount of active compound to a single liposome carrier; bioavailability; image-enhanced contrast agents for imaging (MRI); tissue-targeted therapy |
| 08/23/2007 | US20070196283 Composition for transfection of DNA into the liver |
| 08/23/2007 | US20070196282 Medical diagnostic ultrasound with temperature-dependent contrast agents |
| 08/23/2007 | US20070196281 Method and articles for remote magnetically induced treatment of cancer and other diseases, and method for operating such article |
| 08/23/2007 | US20070196280 In vivo magnetic resonance spectroscopy of aspartate transaminase activity |
| 08/23/2007 | US20070196279 Methods for treating progressive neurodegenerative disorders |
| 08/23/2007 | US20070196278 Compositions and methods for locating an internal bleeding site |
| 08/22/2007 | EP1821104A2 Method for diagnosing efficacy of xenotypic antibody therapy |
| 08/22/2007 | EP1820517A2 Non-invasive localization of a light-emitting conjugate in a mammal |
| 08/22/2007 | EP1820495A2 Microspheres for active embolization |
| 08/22/2007 | EP1819731A2 Methods and compositions for immunotherapy and detection of inflammatory and immune-dysregulatory disease, infectious disease, pathologic angiogenesis and cancer |
| 08/22/2007 | EP1819374A1 Contrast agent coated medical device |
| 08/22/2007 | EP1819367A2 Use of endothelin etb receptor agonists and eta receptor antagonists in tumor imaging |
| 08/22/2007 | EP1819366A1 A staining composition for staining an ophthalmic membrane |
| 08/22/2007 | EP1562637B1 Contrast medium for representing lymph nodes |
| 08/22/2007 | CN101022835A Cyanine dyes conjugated with antibodies for the diagnosis of micrometastasis |
| 08/22/2007 | CN101022834A Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein |
| 08/22/2007 | CN101020066A In-situ transplantation process of constructing human liver cancer mouse model |